Skip to main content
Log in

Inhibition of endothelial derived relaxing factor (EDRF) aggravates ischemic acute renal failure in anesthetized rats

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

The relative importance of endothelial derived relaxing factor (EDRF)/nitric oxide (NO) in maintaining kidney function in normal condition and in acute renal failure (ARF) were evaluated in inactin anesthetized rats. ARF was induced by unilateral occlusion of the left renal artery (40 min) followed by reperfusion, with the contralateral kidney serving as normal control. This protocol resulted in marked reductions in renal plasma flow (RPF), glomerular filtration rate (GFR) and increases in fractional sodium excretion (FENa) and urinary protein excretion in the post-ischemic kidney in comparison to the contralateral normal kidney. Administration of the nitric oxide (NO) synthase inhibitor NG — monomethyl-L-arginine (0.25 mg/kg per min, L-NMMA) exacerbated the ischemia-induced changes in renal functions as reflected by further reductions in urine flow (V), GFR, marked sodium wasting and renal edema. Pretreatment of the animals with NO precursor L-arginine (2.5 mg/kg per min, L-Arg) abolished the detrimental effects of L-NMMA in ARE In contrast, D-Arginine (2.5 mg/kg per min, DArg) failed to reverse the detrimental effects of L-NMMA. Infusion of L-Arg alone also resulted in improvements in RPF and GFR in the ischemic kidney. The results of the present study suggest that the function of the ischemic kidney is sustained by EDRF/NO and is thus more sensitive to NO synthase inhibition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Aisaka K, Gross SS, Griffith OW Levi R (1989) NG-methyl-L-arginine, and inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: Does nitric oxide regulate blood pressure in vivo? Biochem Biophys Res Commun 160: 881- 886

    Google Scholar 

  2. Alberola A, Pinilla JM, Quesada T, Romero JC, Salom MG, Salazar FJ (1992) Role of nitric oxide in mediating renal responses to volume expansion. Hypertension 19:780–784

    Google Scholar 

  3. Baylis C, Harton P, Engels K (1990) Endothelial derived relaxing factor controls renal hemodynamics in the normal rat kidney. J Am Soc Nephrol 1:875–881

    Google Scholar 

  4. Berti F, Rossoni, Bianchi G, Alberico, Tettamanti R, Calvani AB, Mantovani M, Prino G (1991) Effects of defibrotide on prostacyclin release from isolated rabbit kidneys and protection from postischemic acute renal failure in vivo. Eicosanoids 4:209–215

    Google Scholar 

  5. Bhardwaj R, Moore PK (1988) Endothelium-derived relaxing factor and the effects of acetylcholine and histamine on resistance blood vessels. Br J Pharmacol 95:835–843

    Google Scholar 

  6. Chin PJS, Long JF (1979) Urinary excretion and tissue accumulation of gentamicin and paraaminohippurate in postischemic rat kidneys. Kidney Int 15:618–623

    Google Scholar 

  7. Conger JD (1983) Vascular abnormalities in the maintenance of acute renal failure. Circ Shock 11:235–244

    Google Scholar 

  8. Cristol JP, Thiemermann C, Mitchell JA, Walder C, Vane JR (1992) Endogenous nitric oxide formulation supports renal blood flow after ischemia-reperfusion injury. Br J Pharmacol 107:198P

    Google Scholar 

  9. Finn WF, Hak LJ, Grossman SH (1987) Protective effect of prostacyclin on postischemic acute renal failure in the rat. Kidney Int 32:479–487

    Google Scholar 

  10. Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (Lond) 288:373–376

    Google Scholar 

  11. Hutchinson PJA, Palmer RMJ, Moncada S (1987) Comparative pharmacology of EDRF and nitric oxide on vascular strips. Eur J Pharmacol 141:445–451

    Google Scholar 

  12. King AJ, Brenner BM (1991) Endothelium-derived vasoactive factors and the renal vasculature. Am J Physiol 260:R653-R662

    Google Scholar 

  13. Kon V, Harris RC, Ichikawa I (1990) A regulatory role for large vessels in organ circulation. Endothelial cells of the main renal artery modulate intrarenal hemodynamics in the rat. J Clin Invest 85:1728–1733

    Google Scholar 

  14. Lahera V, Salom MG, Fiksen-Olsen MJ, Raij L, Romero JC (1990) Effects of NG-monomethyl-L-arginine and L-arginine on acetylcholine renal response. Hypertension 15:659–663

    Google Scholar 

  15. Lahera V, Salom MG, Miranda-Gurdiola M, Moncada S, Romero JC (1991a) Effects of NG-nitro-L-arginine methyl ester on renal function and blood pressure. Am J Physiol 262:F1033-F1037

    Google Scholar 

  16. Lahera V, Salom MG, Fiksen-Olsen MJ, Raij L, Romero JC (1991b) Mediatory role of endothelium-derived nitric oxide in renal vasodilatory and excretory effects of bradykinin. Am J Hypertens 4:260–262

    Google Scholar 

  17. Marsden PA, Brock TA, Ballermann BJ (1990) Glomerular endothelial cells respond to calcium-mobilizing agonists with release of EDRE. Am J Physiol F1295-F1303

  18. Palmer RMJ, Rees DD, Aston DS, Moncada S (1988) L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun 153:1252–1256

    Google Scholar 

  19. Park KH, Rubin LE, Gross SS, Levi R (1992) Nitric oxide is a mediator of hypoxic coronary vasodilation. Relation to adenosine and cyclooxygenase-derived metabolites. Circ Res 71:992–1001

    Google Scholar 

  20. Radermacher J, Klanke B, Schurek HJ, Stolte HF, Frolich JC (1992) Importance of NO/EDRF for glomerular and tubular function: Studies in the isolated perfused rat kidney. Kidney Int 41: 1549–1559

    Google Scholar 

  21. Salazar FJ, Pinilla JM, Lopez F, Romero JC, Quesada T (1992) Renal effects of prolonged synthesis inhibition of endothelium-derived nitric oxide. Hypertension 20:113–117

    Google Scholar 

  22. Tanner GA, Sloan KL, Sophansan S (1973) Effects of renal artery occlusion on kidney function in the rat. Kidney Int 4:377–389

    Google Scholar 

  23. Tolins JP, Raij L (1991) Effects of amino acid infusion on renal hemodynamics: role of endothelial derived relaxing factor. Hypertension 17:1045–1051

    Google Scholar 

  24. Vemulapalli S, Chiu PJS, Chintala MS, Bernardino V (1993) Attenuation of ischemic acute renal failure by phosphoramidon in rats. Pharmacol (in press)

  25. Walder CE, Thiemermann C, Vane JR (1991) The involvement of endothelium-derived relaxing factor in the regulation of renal cortical blood flow in the rat. Br J Pharmacol 102:967–973

    Google Scholar 

  26. Welch WJ, Wilcox CS, Aisaka K, Gross SS, Griffith OW, Fontoura BMA, Maack T, Levi R (1991) Nitric oxide synthesis from L-arginine modulates renal vascular resistance in isolated perfused and intact rat kidneys. J Cardiovasc Pharmacol 17 [Suppl 1]:S165–5168

    Google Scholar 

  27. Yao SK, Ober JC, Krishnaswami A, Ferguson JJ, Anderson HV, Golino P, Buja LM, Willerson JT (1992) Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries. Circulation 86: 1302–1309

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Correspondence to M. S. Chintala at the above address

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chintala, M.S., Chin, P.J., Vemulapalli, S. et al. Inhibition of endothelial derived relaxing factor (EDRF) aggravates ischemic acute renal failure in anesthetized rats. Naunyn-Schmiedeberg's Arch Pharmacol 348, 305–310 (1993). https://doi.org/10.1007/BF00169160

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00169160

Key words

Navigation